Search

Your search keyword '"Sementa, Angela"' showing total 249 results

Search Constraints

Start Over You searched for: Author "Sementa, Angela" Remove constraint Author: "Sementa, Angela"
249 results on '"Sementa, Angela"'

Search Results

1. From the identification of actionable molecular targets to the generation of faithful neuroblastoma patient-derived preclinical models

2. Neuroblastoma Pathology

3. Resection of primary tumor in stage 4S neuroblastoma: a second study by the Italian Neuroblastoma Group

4. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

8. Paediatric Spitzoid Neoplasms: 10-Year Retrospective Study Characterizing Histological, Clinical, Dermoscopic Presentation and FISH Test Results

10. Neuroblastoma Pathology

13. Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study

14. Abstract 3407: The italian personalized medicine program PREME for high-risk neuroblastoma

15. Supplementary table 4 from A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma

16. Data from A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma

17. Supplementary table 2 from A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma

18. Supplementary Table 1 from A Promyelocytic Leukemia Protein–Thrombospondin-2 Axis and the Risk of Relapse in Neuroblastoma

19. Supplemental Figure 4 from The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients

20. Data from The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients

21. Supplemental Figure 2 from The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients

22. Supplemental Methods and Figure Legends from The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients

23. Supplemental Figure 3 from The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients

24. Supplemental Figure 1 from The Neuronal Pentraxin-2 Pathway Is an Unrecognized Target in Human Neuroblastoma, Which Also Offers Prognostic Value in Patients

25. Neuroblastoma (Peripheral neuroblastic tumours)

26. Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology

27. Nucleolin expression has prognostic value in neuroblastoma patients

28. Italian Precision Medicine in Pediatric Oncology: Moving beyond Actionable Alterations

29. Abstract 1276: Nucleolin has prognostic value in neuroblastoma patients

30. IMG-12. Transient atypical brain and spine MRI features after high-dose chemotherapy may represent clumps of CD34+ hematopoietic stem cells

32. NTRK Gene Fusion Detection in Atypical Spitz Tumors

33. Genetic Abnormalities in Adolescents and Young Adults With Neuroblastoma: A Report From the Italian Neuroblastoma Group

34. Atypical Spitz tumors in patients younger than 18 years

35. Additional file 5 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

36. Additional file 3 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

37. Additional file 2 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

38. Additional file 4 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

39. Additional file 9 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

40. Additional file 7 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

41. Additional file 6 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy

42. Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy

43. Natural course of HCV infection in childhood cancer survivors

44. Biallelic variants in LIG3 cause a novel mitochondrial neurogastrointestinal encephalomyopathy

45. Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants

47. Stromal-like Wilms tumor cells induce human Natural Killer cell degranulation and display immunomodulatory properties towards NK cells

Catalog

Books, media, physical & digital resources